Refine Results
  1. "Michel Sadelain"
Formats
  1. Journal Article (249)
  2. Meeting Abstract (248)
  3. Conference Paper (3)
  4. Book Section (2)
Groups
  1. Center for Hematologic Malignancies (502)
  2. GSK Faculty (502)
  3. Hematologic Malignancies Research (502)
  4. Hematologic Malignancies, Division of (502)
  5. Molecular Pharmacology and Chemistry Program Faculty (502)
  6. Sloan Kettering Institute Faculty (502)

More Groups

People
  1. Michel Sadelain (502)
  2. Isabelle Riviere (170)
  3. Renier Brentjens (104)
  4. Xiuyan Wang (72)
  5. Jae Park (59)
  6. Richard O'Reilly (34)

More People

Years
  1. 2021 (1)
  2. 2020 (10)
  3. 2019 (26)
  4. 2018 (28)
  5. 2017 (26)
  6. 2016 (27)

More Years

Publications
  1. Blood (112)
  2. Molecular Therapy (49)
  3. Cancer Research (21)
  4. Journal of Clinical Oncology (18)
  5. Nature Biotechnology (13)
  6. Journal of Thoracic Oncology (12)

More Publications

Publishers
  1. American Society of Hematology (112)
  2. Nature Publishing Group (101)
  3. Elsevier Inc. (47)
  4. American Association for Cancer Research (40)
  5. American Society of Clinical Oncology (19)
  6. Elsevier Science, Inc. (14)

More Publishers

Results (502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy
    Journal Article

    Stone, E. F.; Avecilla, S. T.; Wuest, D. L.; Lomas-Francis, C.; Westhoff, C. M.; Diuguid, D. L.; Sadelain, M.; Boulad, F.; Shi, P. A.
    Haematologica (2021)

    Fulltext@MSK | Save
  • FT819 path to IND: First-of-kind off-the-shelf CAR19 T-cell for B cell malignancies
    Meeting Abstract

    Mandal, M.; Clarke, R.; van der Stegen, S.; Chang, C. W.; Lai, Y. S.; Witty, A.; Husain, M.; Wu, C. J.; Yang, B. H.; Dufaud, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Regional delivery of clinical-grade mesothelin-targeted CAR T cells with cell-intrinsic PD-1 checkpoint blockade: Translation to a phase I trial
    Meeting Abstract

    Kiesgen, S.; Linot, C.; Quach, H. T.; Saini, J.; Bellis, R.; Banerjee, S.; Hou, Z.; Chintala, N. K.; Sadelain, M.; Adusumilli, P. S.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomics of multiple myeloma influences the expression of CAR T-cell targets
    Meeting Abstract

    Yu, C.; Walker, B.; Roodman, G. D.; Huang, K.; Sadelain, M.; Perna, F.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Senolytic CAR T cells reverse senescence-associated pathologies
    Journal Article

    Amor, C.; Feucht, J.; Leibold, J.; Ho, Y. J.; Zhu, C.; Alonso-Curbelo, D.; Mansilla-Soto, J.; Boyer, J. A.; Li, X.; Giavridis, T.; more...
    Nature (2020)

    Fulltext@MSK | Save
  • Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
    Journal Article

    Imber, B. S.; Sadelain, M.; DeSelm, C.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Giralt, S.; Park, J. H.; Sauter, C.; Scordo, M.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Co-targeting CD38 with a chimeric costimulatory receptor enhances adoptive T cell therapy for hematological malignancies
    Meeting Abstract

    Katsarou, A.; Sjostrand, M. L.; Nianias, A.; Poels, R.; Zweegman, S.; Mutis, T.; Sadelain, M.; Groen, R. W. J.; Themeli, M.
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Establishing cGMP manufacturing of CRISPR/Cas9-edited human CAR T cells
    Meeting Abstract

    Wang, X.; Zabierowski, S. E.; Wu, M.; Zhu, M.; Del Casale, C.; Eyquem, J. E.; Mansilla-Soto, J.; Sadelain, M.; Riviere, I.
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • Establishing cGMP manufacturing of CRISPR/Cas9-edited human CAR T cells
    Meeting Abstract

    Wang, X.; Zabierowski, S.; Wu, M.; Del Casale, C.; Eyquem, J.; Mansilla-Soto, J.; Riviere, I.; Sadelain, M.
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save